Access hsTnI (High Sensitivity Troponin I Assay)

High-quality

• Delivers quality results with a new robust design to minimize the effects of pre-analytical variability and known interferences
• Demonstrates optimal precision at concentrations ~10x lower than previous generations of assays

Accurate

• Accurately identifies ≥94% of true acute myocardial infarction (AMI) patients in as little as one hour after presentation
• Enables more accurate identification of women with AMI by providing separate sex-specific upper reference limits
• Provides >99% confidence in ruling out AMI when a patient’s troponin result is below the URL

Timely

• Enables easier interpretation of test results by using whole-number reporting
• Increases testing flexibility as the only high-sensitivity assay to use either plasma or serum samples

Access hsTnI delivers tangible advances in patient care

A multicenter prospective study to establish the 99th percentile URL in a population of healthy adults was conducted. Study participants had no known cardiovascular diseases, other acute or chronic diseases, or infections. (See Tables 1 and 2.)

Table 1. 99th Percentile URL of a Healthy Population: UniCel DxI

Table 2. 99th Percentile URL of a Healthy Population: Access 2

Access hsTnI provides sex-specific cutoff values.

Assay details